Sample Page
Author:
Balt Group
Posted Date:
February 4, 2026
Balt’s Squid™ Liquid Embolic Receives FDA Approval for Adjunctive Treatment for Patients with Chronic Subdural Hematomas
Balt Group
February 4, 2026